Sunshine Biopharma
SBFM
2 hedge funds and large institutions have $111K invested in Sunshine Biopharma in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 5 closing their positions.
67% more capital inflows, than outflows
Capital inflows: $149K | Capital outflows: $89.1K
60% less funds holding
Funds holding: 5 → 2 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$146K |
| 2 |
Nordwand Advisors
Radnor,
Pennsylvania
|
+$2.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$32.1K |
| 2 |
XTX Topco
George Town,
Cayman Islands
|
-$18.4K |
| 3 |
HRT Financial
New York
|
-$18K |
| 4 |
Jane Street
New York
|
-$11.6K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$8.35K |
SBFM Hedge Fund Activity: Q3 2024 in Review
2 of the 6,991 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q3 2024, worth a combined $111K — up 24% from $89.6K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of SBFM and 2 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Bank of America, opening a new position worth an estimated $146K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $32.1K sold.
- 2 institutional investors held Sunshine Biopharma (SBFM) as of Q3 2024, down from 5 in Q2 2024.
- Funds reported $111K of Sunshine Biopharma stock for Q3 2024, up 24% quarter-over-quarter.
- 2 funds opened new Sunshine Biopharma positions in Q3 2024 and 5 closed out, a net change of -3 holders.
- The largest Sunshine Biopharma buyer in Q3 2024 was Bank of America, an estimated $146K added.
- The largest Sunshine Biopharma seller in Q3 2024 was Susquehanna International Group, an estimated $32.1K sold.
Based on aggregated 13F filings for Q3 2024.